![Patrick Stragier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Stragier
Director/Miembro de la Junta en
Dendrogenix SA
.
Perfil
Patrick Stragier is the founder of MaSTherCell SA, which was founded in 2010.
He held the title of COO & CBO from 2010 to 2015.
Currently, he is a Director at Dendrogenix SA and an Investment Manager at Noshaq SA, where he started in 2021.
Previously, he worked as a Director of Clinical Manufacturing at Genzyme Flanders BVBA from 2000 to 2002, as Managing Director at Lonza Verviers from 2002 to 2009, as Cell Therapy Platform Director at BioWin ASBL from 2009 to 2010, as Vice President-Operations at PROMETHERA Biosciences SA from 2015 to 2017, as General Manager at Catalent Belgium SA from 2020 to 2021, and as Chief Transformation Officer at Cell Matters SA from 2021 to 2022.
Cargos activos de Patrick Stragier
| Empresas | Cargo | Inicio |
|---|---|---|
Noshaq SA
 Noshaq SA Investment ManagersFinance Noshaq SA is an active manager which invests in companies located in Belgium with a focus on the Liège area. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed stage, early stage, later stage and growth stage. | Inversor de Capital Privado | 01/11/2021 |
Dendrogenix SA
 Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Patrick Stragier.
| Empresas | Cargo | Fin |
|---|---|---|
Cell Matters SA
 Cell Matters SA BiotechnologyHealth Technology Engages in cryo-processing and cryopreservation solutions | Corporate Officer/Principal | 01/10/2022 |
Catalent Belgium SA
 Catalent Belgium SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01/08/2021 |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Corporate Officer/Principal | 01/10/2017 |
Catalent Gosselies NV
 Catalent Gosselies NV BiotechnologyHealth Technology Provides cell therapy manufacturing services | Fundador | 01/05/2015 |
BioWin ASBL
 BioWin ASBL Miscellaneous Commercial ServicesCommercial Services Provides support for research and development of biomarkers | Corporate Officer/Principal | 01/07/2010 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
12
Relaciones de 1er grado
9
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 9 |
|---|---|
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an active manager which invests in companies located in Belgium with a focus on the Liège area. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed stage, early stage, later stage and growth stage. | Finance |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Health Technology |
Catalent Belgium SA
Catalent Belgium SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Genzyme Flanders BV
 Genzyme Flanders BV BiotechnologyHealth Technology Develops and manufactures biotherapeutic products | Health Technology |
Lonza Verviers
 Lonza Verviers Chemicals: SpecialtyProcess Industries Manufactures industrial organic chemicals | Process Industries |
BioWin ASBL
BioWin ASBL Miscellaneous Commercial ServicesCommercial Services Provides support for research and development of biomarkers | Commercial Services |
Catalent Gosselies NV
Catalent Gosselies NV BiotechnologyHealth Technology Provides cell therapy manufacturing services | Health Technology |
Cell Matters SA
Cell Matters SA BiotechnologyHealth Technology Engages in cryo-processing and cryopreservation solutions | Health Technology |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer | Health Technology |
- Bolsa de valores
- Insiders
- Patrick Stragier
